Felbamate (Page 8 of 9)


Felbamate Tablets, USP, 400 mg, are yellow, scored, capsule-shaped tablets, debossed WP 0320 on one side and plain on the other; available in bottles of 100 (NDC 51525-0430-1). Felbamate Tablets, USP, 600 mg, are peach-colored, scored, capsule-shaped tablets, debossed WP 0321 on one side and plain on the other; available in bottles of 100 (NDC 51525-0431-1). Felbamate Oral Suspension, USP, 600 mg/5 mL, is peach-colored; available in 8 oz bottles (NDC51525-0442-8) and 32 oz bottles (NDC51525-0442-3).

Shake suspension well before using. Store at controlled room temperature 20°-25°C (68°-77°F). Dispense in tight container.

To report SUSPECTED ADVERSE REACTIONS, contact Wallace Pharmaceuticals Inc. at 1-800-352-4047 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Manufactured for:
Wallace Pharmaceuticals Inc.
Somerset, NJ 08873-4120 U.S.A.

IN-0321-03/140906-0218 Rev. 2/2018

SOV-IN-0321-03/500490-01 Rev. 2/2018


All patients treated with Felbamate should acknowledge that they understand the risks and other information about Felbamate discussed below, and physicians should acknowledge this discussion.

Felbamate, taken by itself or with other prescription and/or non-prescription drugs, can result in a severe, potentially fatal blood abnormality (“aplastic anemia”) and/or severe, potentially fatal liver damage.


Do not sign this form if there is anything you do not understand about the information you have received. Ask your doctor about anything you do not understand before you initial any of the items below or sign this form.

My [My son, daughter, ward _______________’s] treatment with Felbamate has been personally explained to me by Dr.____________________. The following points of information, among others, have been specifically discussed and made clear and I have had the opportunity to ask any questions concerning this information:

1. I, ____________________ (Patient’s Name), understand that Felbamate is used to treat certain types of seizures and my physician has told me that I have this type(s) of seizures;

2. I understand that Felbamate is being used because my seizures have not been satisfactorily treated with other antiepileptic drugs;

3. I understand that there is a serious risk that I could develop aplastic anemia and/or liver failure, both of which are potentially fatal, by using Felbamate;

4. I understand that there are no laboratory tests which will predict if I am at an increased risk for one of the potentially fatal conditions;

5. I understand that I should have the recommended blood work before my treatment with Felbamate is begun (baseline) and periodically thereafter as clinical judgement warrants. I understand that although this blood work may help detect if I develop one of these conditions, it may do so only after significant, irreversible and potentially fatal damage has already occurred;

6. If I am currently taking other antiepileptic drugs, I understand that the manufacturer of Felbamate recommends that the dosage of these other drugs be decreased by a certain amount when Felbamate is started; if my physician determines that this should not be done in my case, he/she has explained the reason(s) for this decision;

7. I understand that I must immediately report any unusual symptoms to Dr.__________________ and be especially aware of any rashes, easy bruising, bleeding, sore throats, fever, and/or dark urine;

8. I understand that antiepileptic drugs such as Felbamate may increase the risk of suicidal thoughts and behavior. I understand that I must immediately report any unusual changes in mood or behavior, symptoms of depression or thoughts about self-harm to Dr.______________________.
INITIALS: ______________________________

Patient, Parent, or Guardian



I have fully explained to the patient, ____________________ , the nature and purpose of the treatment with Felbamate and the potential risks associated with that treatment. I have asked the patient if he/she has any questions regarding this treatment or the risks and have answered those questions to the best of my ability. I also acknowledge that I have read and understand the prescribing information.
Physician Date

Revised: 7/11

NOTE TO PHYSICIAN: It is strongly recommended that you retain a signed copy of the Patient/Physician Acknowledgment Form with the patient’s medical records.

SUPPLY OF PATIENT/PHYSICIAN ACKNOWLEDGMENT FORMS: A supply of “Patient/Physician Acknowledgement ” Forms as printed above is available, free of charge, from your local Wallace Pharmaceuticals representative, or may be obtained by calling 1-800-352-4047. Permission to use the above Patient/Physician Acknowledgment Form by photocopy reproduction is also hereby granted by Wallace Pharmaceuticals Inc.

Wallace Pharmaceuticals™

Medication Guide

FELBAMATE Tablets and Oral Suspension

IS-0321-02 Rev. 2/2018

SOV-IS-0321-02 Rev. 2/2018

Read this Medication Guide before you start taking FELBAMATE and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.

What is the most important information I should know about FELBAMATE?
Do not stop taking FELBAMATE without first talking to your healthcare provider.
Stopping FELBAMATE suddenly can cause serious problems.

FELBAMATE can cause serious side effects, including:

1. FELBAMATE may cause serious blood problems that may be life-threatening.
Call your healthcare provider right away if you have any of the following symptoms:

Fever, sore throat or other infections that come and go or do not go away
Frequent infections or an infection that does not go away
Easy bruising
Red or purple spots on your body
Bleeding gums or nose bleeds
Severe fatigue or weakness

2. Liver problems that may be life-threatening. Call your healthcare provider right away if you have any of these symptoms:

yellowing of your skin or the whites of your eyes (jaundice)
dark urine
nausea or vomiting
loss of appetite
pain on the right side of your stomach (abdomen)

3. Like other antiepileptic drugs, FELBAMATE may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.

Call your healthcare provider right away if you have any of these symptoms,
especially if they are new, worse, or worry you:

thoughts about suicide or dying
attempts to commit suicide
new or worse depression
new or worse anxiety
feeling agitated or restless
panic attacks
trouble sleeping (insomnia)
new or worse irritability
acting aggressive, being angry, or violent
acting on dangerous impulses
an extreme increase in activity and talking (mania)
other unusual changes in behavior or mood

How can I watch for early symptoms of suicidal thoughts and actions?

Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings.
Keep all follow-up visits with your healthcare provider as scheduled.

Call your healthcare provider between visits as needed, especially if you are worried about symptoms.

Do not stop FELBAMATE without first talking to a healthcare provider.

Stopping FELBAMATE suddenly can cause serious problems. You should talk to your health care provider before stopping. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures.

Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes.


FELBAMATE is a prescription medicine used when other treatments have failed in:

adults alone or with other medicines to treat:
partial seizures with and without generalization
children with other medicines to treat:
seizures associated with Lennox-Gastaut syndrome

Who should not take FELBAMATE?

Do not take FELBAMATE if you:

are allergic to felbamate, carbamates or any of the ingredients in FELBAMATE. See the end of this Medication Guide for a complete list of ingredients in FELBAMATE.
have or have had blood problems
have or have had liver problems

What should I tell my healthcare provider before taking FELBAMATE?

Before you take FELBAMATE, tell your healthcare provider if you:

have kidney problems
have or have had depression, mood problems, or suicidal thoughts or behavior
have any other medical conditions
are pregnant or plan to become pregnant. It is not known if FELBAMATE can harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking FELBAMATE. You and your healthcare provider will decide if you should take FELBAMATE while you are pregnant.
If you become pregnant while taking FELBAMATE, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. The purpose of this registry is to collect information about the safety of antiepileptic medicine during pregnancy. You can enroll in this registry by calling 1-888-233-2334.
are breastfeeding or plan to breastfeed. FELBAMATE may pass into your breast milk. You and your healthcare provider should decide if you should take FELBAMATE while you breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Taking FELBAMATE with certain other medicines can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.

Know the medicines you take. Keep a list of them and show it to your healthcare provider and pharmacist when you get a new medicine.

How should I take FELBAMATE?

Take FELBAMATE exactly as your healthcare provider tells you. Your healthcare provider will tell you how much FELBAMATE to take and when to take it.
Your healthcare provider may change your dose of FELBAMATE. Do not change your dose of FELBAMATE without talking to your healthcare provider.
Because of the risk of serious blood and liver problems, your healthcare provider may do blood tests before you start and while you take FELBAMATE.
If you take too much FELBAMATE, call your healthcare provider or local Poison Control Center right away.
Do not stop FELBAMATE without first talking to your healthcare provider.

What should I avoid while taking FELBAMATE?

FELBAMATE can cause drowsiness and dizziness. Do not drink alcohol or take other medicines that make you sleepy or dizzy while taking FELBAMATE, until you talk with your doctor. Taking FELBAMATE with alcohol or drugs that cause sleepiness or dizziness may make your sleepiness or dizziness worse.

What are the possible side effects of FELBAMATE?

See “What is the most important information I should know about FELBAMATE?”

FELBAMATE may cause serious side effects including:

The most common side effects of FELBAMATE include:

weight loss
trouble sleeping
changes in the way that food tastes

These are not all the possible side effects of FELBAMATE. For more information, ask your healthcare provider or pharmacist.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store FELBAMATE?

Store FELBAMATE at room temperature between 68°F to 77°F (20°C to 25°C).

Keep FELBAMATE and all medicines out of the reach of children.

General information about FELBAMATE.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use FELBAMATE for a condition for which it was not prescribed. Do not give FELBAMATE to other people, even if they have the same symptoms that you have. It may harm them.

This Medication Guide summarizes the most important information about FELBAMATE. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about FELBAMATE that is written for health professionals.

What are the ingredients in FELBAMATE?

Active Ingredient: felbamate

Tablet Inactive Ingredients: starch, microcrystalline cellulose, croscarmellose sodium, lactose, magnesium stearate, FD&C yellow No. 6, D&C Yellow No. 10, and FD&C Red No. 40 (600 mg tablets only).

Suspension Inactive Ingredients: sorbitol, glycerin, microcrystalline cellulose, carboxymethylcellulose sodium, simethicone, polysorbate 80, methylparaben, saccharain sodium, propylparaben, FD&C Yellow No. 6, FD&C Red No. 40, flavorings, and purified water.

For more information, go to wallacepharmaceuticals.com or call 1-800-352-4047.

This Medication Guide has been approved by the U.S. Food and Drug Administration.

Manufactured for:
Wallace Pharmaceuticals Inc.
Somerset, NJ 08873-4120 U.S.A.

Issued 02/18

IS-0321-02 Rev. 2/2018

SOV-IS-0321-02 Rev. 2/2018

Rx Only

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.